Results 171 to 180 of about 4,282,960 (349)

Comprehensive bibliographic study of the framework of complex generic drugs. [PDF]

J Taibah Univ Med Sci
Sreedevi A, Ligade VS, Dewan S.
europepmc   +1 more source

Price Growth for Brand Name and Specialty Drugs Offset Price Decreases for Generic Drugs

Stephen W. Schondelmeyer, Leigh Purvis
openalex   +1 more source

Mechanisms of Aristolochic Acid Resistance in Specialist Butterflies and Evolutionary Insights for Potential Protective Pathways

Advanced Science, EarlyView.
The study provides an extreme example of insect adaptation to highly toxic defenses of host plants, and investigates the complex strategies to resist carcinogenic aristolochic acids, including physical isolation, metabolic detoxification, and DNA repair.
Yang Luan, Yubo Zhang, Jingjing Li, Jianqing Zhu, Yuyang Lei, Yushi Hu, Zhenqiang Xin, Tianpei Xie, Jiang Zheng, Yuanyuan Lin, Jingjing Shen, Yiyi Cao, Xinyue You, Jing Xi, Jiaying Wu, Weiying Liu, Xinyu Zhang, Yuanting Zheng, David J. Lohman, Leming Shi, Wei Zhang   +20 more
wiley   +1 more source

Frequency of first generic drugs approved through "skinny labeling," 2021 to 2023. [PDF]

J Manag Care Spec Pharm
Ziaks TJ, Akanegbu CM, Egilman AC, Kesselheim AS.   +3 more
europepmc   +1 more source

Antimicrobial drug-nutrition interactions: Consistency of information for generic drugs

, 2018
Božana Nikolić
openalex   +2 more sources

Inferring Gene Regulatory Networks From Single‐Cell RNA Sequencing Data by Dual‐Role Graph Contrastive Learning

Advanced Science, EarlyView.
RegGAIN is a novel and powerful deep learning framework for inferring gene regulatory networks (GRNs) from single‐cell RNA sequencing data. By integrating self‐supervised contrastive learning with dual‐role gene representations, it consistently outperforms existing methods in both accuracy and robustness.
Qiyuan Guan, Jiating Yu, Jieyi Pan, Fan Yuan, Jiadong Ji, Rusong Zhao, Zhi‐Ping Liu, Bingqiang Liu, Ling‐Yun Wu, Duanchen Sun   +9 more
wiley   +1 more source

Innovating Branding Strategies for Generic Drugs

Rohan Dave, Dr.Bijal Zaveri
openalex   +1 more source

Comparison of Generic‐to‐Brand Switchback Rates Between Generic and Authorized Generic Drugs

Pharmacotherapy, 2017
R. Hansen, J. Qian, R. Berg, J. Linneman, E. Seoane-Vazquez, S. Dutcher, S. Raofi, C. D. Page, P. Peissig   +8 more
semanticscholar   +1 more source

Nanozymes Integrated Biochips Toward Smart Detection System

Advanced Science, EarlyView.
This review systematically outlines the integration of nanozymes, biochips, and artificial intelligence (AI) for intelligent biosensing. It details how their convergence enhances signal amplification, enables portable detection, and improves data interpretation.
Dongyu Chen, Wang Zheng, Zhihui Zhang, Shenping Yu, Xinxin Hang, Han Wu, Xiao‐Wei Xiang, Wei Mu, Yanli Jiao, Zaizai Dong, Lingqian Chang   +10 more
wiley   +1 more source

Exploring SARS-CoV‑2 Spike RBD Pockets as Targets for Generic Drugs: A Combined Computational, Biophysical, and Biological Approach. [PDF]

ACS Omega
García-Marín J, Francés-Gómez C, Forcada-Nadal A, Adhav A, Marco-Marín C, Rubio V, Marina A, Llácer JL, Geller R, Martín-Santamaría S.   +9 more
europepmc   +1 more source